Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study
Andrew L. Feldman(Mayo Clinic in Arizona), Stephen M. Ansell(Mayo Clinic), Stefania Pittaluga(New York University), Yu Zeng(Tongji University), Giorgio Inghirami(Cornell University), Pedro Farinha, Weina Chen(Army Medical University), Lisa M. Rimsza(Banner - University Medical Center Tucson), Wing C. Chan(Ontario Institute for Cancer Research), Kerry J. Savage(Spinal Cord Injury BC), Ryan A. Wilcox(University of Michigan), David W. Scott(BC Cancer Agency), Anamarija M. Perry(University of Michigan), Louis M. Staudt(National Cancer Institute), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Joo Y. Song(City Of Hope National Medical Center), Elı́as Campo(Hospital Clínic de Barcelona), Philipp W. Raess(Oregon Health & Science University), Young Hyeh Ko(Cheju Halla General Hospital), Timothy C. Greiner(University of Nebraska Medical Center), Sarah L. Ondrejka(Cleveland Clinic), Liuyan Jiang(Jacksonville College), Javeed Iqbal(University of Nebraska Medical Center), Eric Mou(Stanford University), Graham W. Slack(BC Cancer Agency), Akira Satou(Nagoya University Hospital), Matthew J. Maurer(Mayo Clinic in Arizona), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Surendra Dasari(Mayo Clinic in Arizona), James R. Cook(Cleveland Clinic), Susan L. Slager(Mayo Clinic), Brad S. Kahl(UW Health University Hospital), David L. Jaye(Emory University), Laurence de Leval(University Hospital of Lausanne), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), James R. Cerhan(Mayo Clinic), Kennosuke Karube(Nagoya University), Naoki Oishi(University of Yamanashi), Jan Delabie, George W. Wright(National Cancer Institute), Elaine S. Jaffe(National Cancer Institute), Hao‐Wei Wang(Fu Jen Catholic University), Xiaojun Wu(Johns Hopkins University), Carlos Barrionuevo(National University of San Marcos), Xueju Wang(Mayo Clinic), Catalina Amador(University of Miami), Tadashi Yoshino(Okayama University), L. Jeffrey Medeiros(Delaware Division of Libraries), Jennifer R. Chapman‐Fredricks(University of Miami), Kai Fu(Soochow University)
Cited by 3
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k